Irreversible inactivation of the opiate receptors in the neuroblastoma x glioma hybrid NG108-15 by chlornaltrexamine.
D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives*; D004745:Enkephalins / Q000494:pharmacology; D005910:Glioma / Q000378:metabolism*; D006822:Hybrid Cells / Q000378:metabolism; D051379:Mice; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009374:Neoplasms, Experimental / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism*; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects* / Q000378:metabolism
D004745:Enkephalins; D009588:Nitrogen Mustard Compounds; D011459:Prostaglandins E, Synthetic; D011957:Receptors, Opioid; D009270:Naloxone; D004744:Enkephalin, Methionine; D009271:Naltrexone; C022118:enkephalinamide-Met, Ala(2)-; C017120:chlornaltrexamine; D000242:Cyclic AMP